Morgan Welch Program’s 10th Anniversary conference manuscripts published in the Journal of Cancer
Morgan Welch Program’s 10th Anniversary conference manuscripts published in the Journal of Cancer We are pleased to announce that all 3 manuscripts describing the proceedings from the Morgan Welch Program’s 10th Anniversary conference have now been...
Dr. Mark Schaverien Discusses Lymphedema
Our founder, Terry Lynn Arnold, has been speaking about her recent lymphedema bypass surgeries to alleviate her battle with lymphedema. In this podcast presented by Cancer Newsline, her surgeon, Dr. Mark Schaverien discusses the causes and effects of lymphedema....
IBC Research Update: The role of drugs named “statin”
The following is an update from Naoto T. Ueno, M.D., Ph.D. Executive Director, The University of Texas MD Anderson Cancer Center Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX Inflammatory breast cancer (IBC) is the most lethal and...
IBC Research update: The role of the protein molecule Axl
The following is an update from Naoto T. Ueno, M.D., Ph.D. Executive Director, The University of Texas MD Anderson Cancer Center Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX Inflammatory breast cancer (IBC) is the most lethal...
